Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell linesKaren Bräutigam, Frank Köster|Journal of Cancer Research and Clinical Oncology|2021Cited by 18